Bioresorbable Coronary Stents Market Size & Forecast Report, 2016 - 2025

The global Bioresorbable Coronary Stents Market size is expected to value at USD 247 million by 2025. The market is subject to witness substantial growth due to the easy availability of post-approved with and tested lab results for Magmaris, Magnitude, and next-generation Absorb bioresorbable vascular scaffold (BVS) system.

Early adoption of bioresorbable devices allows patients to live a normal life with regular monitoring of the artery. Bioresorbable devices also offer options to undergo angioplasty in later stages in a patient’s life. Globally, the bioresorbable coronary stents industry is predicted to grow at a CAGR of 15% in the forecast period, providing numerous opportunities for market players to invest in research and development in the market.

The pediatric patient suffering from genetic coronary conditions is are targeted audience for fully dissolvable stents that enable normal functioning of vasomotor functions and vessel growth, thus driving the market demand for bioresorbable coronary stents market in recent years. The rising adoption of elective percutaneous coronary intervention or PCI techniques is one of the critical factors responsible for the growth of the market.

The increasing prevalence of cardiovascular diseases, stroke, coronary artery disease, and atherosclerosis are giving rise to a growing number of concerns among healthcare professionals and governmental agencies considering the severity of these diseases. Changing food patterns, unhealthy lifestyles, and obesity in urban areas across the globe are major risk factors leading to a rise in the incidence of stroke conditions, thus, driving the demand for interventional coronary procedures among the young population.

The absence of primary guidelines to monitor procedure volumes and high approval rates by government agencies in various regions across the globe are anticipated to fuel the growth of the market. The Absorb bioresorbable vascular scaffold (BVS) is one of the fastest-growing segments in the bioresorbable coronary stents industry with the highest revenue generation in the last couple of years. Though, unfavorable post-approval lab results are significantly hampering the sales of Absorb bioresorbable vascular scaffold (BVS) systems due to concerns for the safety and operational capability of such fully dissolvable devices. Thus, the rising need for more reliable and tested solutions coupled with post-approval data from governmental regulatory agencies, are opening up the market for lesser-known stents like Me Res-100 and DESolve in coming years.

Growing competition in the bioresorbable coronary stents market is expected to boost the market growth in upcoming years. An increasing number of joint ventures, acquisitions, and mergers by industry leaders for the development of innovative products in the market are further solidifying market demand. Advent metallic bioresorbable device termed as Magmaris that consists of the metallic body are capable of exerting higher radial force, compared to its counterparts in the market.

Numerous industry players are significantly investing in the development of advanced bioresorbable coronary stent such as second-generation Absorb bioresorbable vascular scaffold (BVS) systems to gain a competitive edge in the market. A bioresorbable coronary stent is directly inserted into a blood vessel or other internal duct to completely avoid any blockage in the flow of the blood. Such critical advantages of the bioresorbable coronary stent are driving market growth in recent years.

The bioresorbable coronary stents industry is divided into regional market segments such as North America, Europe, Asia-Pacific, Latin America, and Africa. The European region has shown major growth in recent years owing to easy accessibility of CE-approved stents, lack of presence for regular auditing checks, rise in the adoption of latest technologies, and existence of well-established healthcare infrastructure.

Asia-Pacific region is predicted to hold a major market share in the bioresorbable coronary stents market with massive growth in the forecast period. Countries such as India, China, and Japan are leading the Asia-Pacific market with rising in the patient pool and increasing investment by industry leaders considering potential opportunities in the region.

The key players in the bioresorbable coronary stents industry are BIOTRONIK Incorporations, Meril Lifesciences Private Limited., Elixir Medical Co., REVA Medical Incorporations, Arterial Remodeling Technologies S.A., Amaranth Medical Incorporations, Microport Scientific Co., and Arterius Limited.

Market Segment:

Bioresorbable Coronary Stents Brand Outlook (Revenue, USD Million; 2016 - 2025)
    • Absorb BVS
    • Absorb 2nd Generation
    • Magmaris
    • Magnitude
    • MeRes-100
    • DESolve

Bioresorbable Coronary Stents Regional Outlook (Revenue, USD Million; 2016 - 2025)
    • North America
        • the U.S.
        • Canada
    • Europe
        • the UK
        • Germany
        • France
        • Italy
        • Spain
    • the Asia Pacific
        • Japan
        • India